Loading data
FUBONYSE
| Unit: USD | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 402.35 m USD | 1.37 bn USD | 1.01 bn USD | 638.37 m USD |
| Research and development expense | 80.01 m USD | 67.68 m USD | 69.26 m USD | 55.42 m USD |
| Operating profit | -196.02 m USD | -289.35 m USD | -411.86 m USD | -328.28 m USD |
| Profit before tax | -177.12 m USD | -293.98 m USD | -426.71 m USD | -354.47 m USD |
| Income tax expense | 659 k USD | -879 k USD | -1.67 m USD | -2.68 m USD |
| Net income (reported basis) | -176.09 m USD | -287.92 m USD | -561.92 m USD | -382.96 m USD |
| Net income attributable to common shareholders | -172.25 m USD | -287.45 m USD | -561.48 m USD | -382.84 m USD |
| Basic earnings per share | -0.54 USD/share | -1.04 USD/share | -3.08 USD/share | -2.78 USD/share |
| Diluted earnings per share | -0.54 USD/share | -1.04 USD/share | -3.08 USD/share | -2.78 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.